Remove Clinical Trials Remove Generic Pharmaceutical Remove HR Remove Trials
article thumbnail

Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz

The Pharma Data

Sandoz is a global leader in generic pharmaceuticals and biosimilars. Its global portfolio covers all major therapeutic areas with a global market leadership position in biosimilars, generic antibiotics and oncology medicines. billion) and Entresto (at least USD 5.0

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. Toujeo generated Sanofi €1.12 Additional revenue came from the acquisition of Alexion Pharmaceuticals in July 2021. billion ($1.17 billion ($3.65

Sales 98